Predicate |
Object |
contentType |
Case Reports|Journal Article |
endingPage |
58 |
issn |
1520-4383 1520-4391 |
issueIdentifier |
1 |
pageRange |
55-58 |
publicationName |
Hematology. American Society of Hematology. Education Program |
startingPage |
55 |
bibliographicCitation |
Tam CS. Upfront therapy: the case for continuous treatment. Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):55–8. PMID: 34889433; PMCID: PMC8791150. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e3b4a9e3cf9798c95aca04095013cd8 |
date |
2021-12-10^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/34889433 https://pubmed.ncbi.nlm.nih.gov/PMC8791150 https://doi.org/10.1182/hematology.2021000232 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/26766 https://portal.issn.org/resource/ISSN/1520-4383 https://portal.issn.org/resource/ISSN/1520-4391 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Upfront therapy: the case for continuous treatment |
discusses |
http://id.nlm.nih.gov/mesh/M0219038 http://id.nlm.nih.gov/mesh/M0474970 http://id.nlm.nih.gov/mesh/M000614617 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0020790 http://id.nlm.nih.gov/mesh/M0028488 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D015451Q000188 http://id.nlm.nih.gov/mesh/D019086Q000627 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D013449Q000627 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D000077329Q000037 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49846579 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e2e9c6d37ebae8d49121718f1271bff2 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108157 |